Table 1

Entry demography of the 41 patients of this study
GMA PSL
Gender: Male/Female 14/10 7/10
Mean age (range) 33.6(15–78) 35.4(13–65)
Extent of UC Total 17 10
Left sided 6 5
Recto-sigmoid 1 2
Clinical course Chronic continuous type 0 1
Relapsing remitting type 28 14
First UC episode 0 2
Inpatient/Outpatient 19/5 17/0
Patients with a history of exposure to PSL 17 13
Patients on AZA (50mg/day) 8 8

GMA, adsorptive granulocyte and monocyte apheresis; PSL, predonisolone; AZA, azathioprine (started ≥8 weeks ahead of entry).

All patients were included following a relapse of ulcerative colitis (UC)

Tominaga et al.

Tominaga et al. BMC Gastroenterology 2013 13:41   doi:10.1186/1471-230X-13-41

Open Data